Arrowhead Pharmaceuticals (NASDAQ:ARWR) reported a larger-than-expected loss for Q1 FY2025, with earnings per share (EPS) at -$1.39, missing the forecast of -$0.39. Revenue also fell short, totaling ...

Q4 2024 Earnings Call Transcript February 6, 2025 Operator: Good day, and welcome to the InMode Fourth Quarter and Full Year ...

Inc. (NASDAQ: BNAI) reported its third-quarter fiscal year 2025 earnings, revealing a significant revenue increase and a narrowing net loss. The company's earnings per share (EPS) matched expectations ...

Q2 2025 Earnings Call Transcript February 7, 2025 Operator: Welcome to the Northeast Bank Second Quarter Fiscal Year 2025 ...

Q4 2024 Earnings Call Transcript February 7, 2025 Green Plains Inc. misses on earnings expectations. Reported EPS is ...

In addition, we may also reference certain non-GAAP measures on the call today, including adjusted EBITDA, adjusted operating income or adjusted earnings ... reflect those of Nasdaq, Inc. Founded ...

Q1 2025 Earnings Call Transcript February 7, 2025 Operator: Good day, everyone, and welcome to the i3 Verticals First Quarter ...

As a reminder, the press release, supplemental earnings presentation, including our guidance and a conference call transcript will be available on our investor relations website, investors.sonos.com.

please read our Q4 and full-year earnings press release and management commentary we posted to the Investor Relations section of GoPro's website. Before I pass the call to Nick, I'd like to remind ...

Reported EPS is $0.3068 EPS, expectations were $0.35. Operator: Good day and thank you for standing by. Welcome to the PAA ...

Good day, and welcome to the InMode fourth quarter and full year 2024 earnings results conference call. [Operator instructions ... necessarily reflect those of Nasdaq, Inc. Founded in 1993 ...